Azenta, Inc.

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences sector. The company operates through two primary segments: Sample Management Solutions and Multiomics. Its Sample Management Solutions business offers automated storage systems, cryogenic devices, sample repository services, automated tubes, controlled-rate thawing devices, and laboratory consumables. Through its Multiomics segment, the company delivers genomic services such as gene sequencing, gene synthesis, and bioinformatics analysis. Azenta serves approximately 14,000 clients globally, including pharmaceutical and biotechnology enterprises, research hospitals, academic organizations, and government institutions.

The company is headquartered in Burlington, Massachusetts, and conducts operations across North America, Europe, and Asia. It generates sales in approximately 95 countries and employs around 3,000 individuals worldwide. Azenta maintains principal manufacturing facilities in the United States and the United Kingdom, alongside a network of 14 genomic services laboratories located across the United States, China, the United Kingdom, Germany, and Japan.

Summary of the business section of Azenta's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“In total, we employ approximately 3,000 full-time employees, part-time employees and contingent workers worldwide as of September 30, 2025, primarily in the United States.”